Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Locally advanced breast cancer in Jamaica: prevalence, disease characteristics and response to preoperative therapy.

Chin SN, Green CM, Gordon-Strachan GM, Wharfe GH.

Asian Pac J Cancer Prev. 2014;15(7):3323-6.

2.

Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.

Solá M, Margelí M, Castellá E, Cirauqui B, Mariscal A, Rull M, Julian JF, Luna M, Vallejo V, Fraile M.

Breast. 2013 Oct;22(5):908-13. doi: 10.1016/j.breast.2013.04.014. Epub 2013 May 15.

PMID:
23683695
3.

Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.

Cho JH, Park JM, Park HS, Park S, Kim SI, Park BW.

J Surg Oncol. 2013 Dec;108(8):531-6. doi: 10.1002/jso.23439. Epub 2013 Sep 30.

PMID:
24115142
4.

Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73.

PMID:
15234040
5.

Neoadjuvant chemotherapy for locally advanced breast cancer in a malaysian tertiary hospital.

Azrif M, Ibrahim J, Aslan NM, Fong KV, Ismail F.

Asian Pac J Cancer Prev. 2011;12(1):157-62.

6.

Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.

Semiglazov V, Eiermann W, Zambetti M, Manikhas A, Bozhok A, Lluch A, Tjulandin S, Sabadell MD, Caballero A, Valagussa P, Baselga J, Gianni L.

Eur J Surg Oncol. 2011 Oct;37(10):856-63. doi: 10.1016/j.ejso.2011.07.003. Epub 2011 Aug 16.

PMID:
21843921
7.

Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.

Garimella V, Qutob O, Fox JN, Long ED, Chaturvedi A, Turnbull LW, Drew PJ.

Eur J Surg Oncol. 2007 Mar;33(2):157-61. Epub 2006 Nov 7.

PMID:
17085007
8.

Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.

Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M 2nd.

Ann Surg. 2002 Sep;236(3):295-302; discussion 302-3.

9.

Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.

Chen XS, Wu JY, Huang O, Chen CM, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

Oncol Rep. 2010 May;23(5):1213-20.

PMID:
20372832
10.

Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate.

Sweeting RS, Klauber-Demore N, Meyers MO, Deal AM, Burrows EM, Drobish AA, Anders CK, Carey LA.

Am Surg. 2011 Jul;77(7):850-5.

11.

Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.

Wang YJ, Huang XY, Mo M, Li JW, Jia XQ, Shao ZM, Shen ZZ, Wu J, Liu GY.

Asian Pac J Cancer Prev. 2015;16(11):4603-8.

12.

Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.

Alvarado-Miranda A, Arrieta O, Gamboa-Vignolle C, Saavedra-Perez D, Morales-Barrera R, Bargallo-Rocha E, Zinser-Sierra J, Perez-Sanchez V, Ramirez-Ugalde T, Lara-Medina F.

Radiat Oncol. 2009 Jul 11;4:24. doi: 10.1186/1748-717X-4-24.

13.

Neoadjuvant chemotherapy in locally advanced breast cancer.

Iqbal J, Shafi AA, Alharthi BN.

J Coll Physicians Surg Pak. 2014 Nov;24(11):845-8. doi: 11.2014/JCPSP.845848.

PMID:
25404445
14.

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.

Miglietta L, Morabito F, Provinciali N, Canobbio L, Meszaros P, Naso C, Murialdo R, Boitano M, Salvi S, Ferrarini M.

Eur J Surg Oncol. 2013 Oct;39(10):1046-52. doi: 10.1016/j.ejso.2013.06.024. Epub 2013 Jul 26.

PMID:
23890870
15.
16.

Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.

Choi MK, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Cancer Chemother Pharmacol. 2014 Sep;74(3):521-9. doi: 10.1007/s00280-014-2542-5. Epub 2014 Jul 22.

PMID:
25047725
17.

Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome.

Ozmen V, Cabioglu N, Dolay K, Bilir A, Kecer M, Aydiner A, Muslumanoglu M, Igci A, Bozfakioglu Y, Dagoglu T.

Breast Cancer Res Treat. 2001 Jul;68(2):147-57.

PMID:
11688518
18.

IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.

Fastner G, Reitsamer R, Ziegler I, Zehentmayr F, Fussl C, Kopp P, Peintinger F, Greil R, Fischer T, Deutschmann H, Sedlmayer F.

Int J Cancer. 2015 Mar 1;136(5):1193-201. doi: 10.1002/ijc.29064. Epub 2014 Jul 10.

19.

Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.

Graham PJ, Brar MS, Foster T, McCall M, Bouchard-Fortier A, Temple W, Quan ML.

Ann Surg Oncol. 2015 Oct;22(10):3376-82. doi: 10.1245/s10434-015-4714-x. Epub 2015 Jul 23.

PMID:
26202561
20.

[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Cancer Radiother. 2004 Jun;8(3):155-67. French.

PMID:
15217583

Supplemental Content

Support Center